ArticleOncogene2003

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.

Norihiro Sato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.